Bipolar disorder affects 40-50 million people globally, with genetic heritability between 60-80%, and can be triggered by both positive and negative life events, including promotions or new ...

Genomic psychiatry is reshaping how we treat bipolar disorder—using genes to predict lithium response and personalize mental ...

When we think about treating bipolar I disorder (BD-I), the conversation often starts with pharmacotherapy as medication ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for depression, bipolar disorder, and more.

Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment ...

Study: CaMKK2 as an emerging treatment target for bipolar disorder. Image Credit: Tunatura / Shutterstock.com. ... as it has important functions in neurotransmitter release and gene expression.

Many individuals with bipolar disorder do not respond well to medication, and previous studies have shown that their gut microbiomes differ from those of healthy individuals. This difference is ...

Bipolar disorder is a mental health condition that is characterized by dramatic mood episodes that include mania or hypomania. These “high” moods alternate with periods of depression.

Who Gets Mixed Bipolar Episodes? About 2.6% of the U.S. population -- nearly 6 million people -- has some form of bipolar disorder. Mixed episodes are common in people with bipolar disorder ...